Immuron Limited - Warrants (12/05/2022) Profit Margin

Immuron Limited - Warrants (12/05/2022) posts a profit margin of -59.97% as of June 2026. That compares with -105.94% in the prior-year period — up 43.4% year over year. That is below the Healthcare sector average of 21.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Immuron Limited - Warrants (12/05/2022)'s profit margin was -105.94%. The latest reading is -59.97% — a 43.4% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.34% is typical. Immuron Limited - Warrants (12/05/2022)'s -59.97% is lower that level. That is roughly 381.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Immuron Limited - Warrants (12/05/2022)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -59.97% as of June 2026; use YoY and peer views to separate noise from signal.

Context for IMRNW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.34%), and (3) consistency with growth and profitability. This page covers the first two; Immuron Limited - Warrants (12/05/2022)'s other metric pages and overview cover the third.